Current recommendations for anticoagulant therapy in patients with valvular heart disease and atrial fibrillation: the ACC/AHA and ESC/EACTS Guidelines in Harmony…but not Lockstep

Saved in:
Bibliographic Details
Published inHeart (British Cardiac Society) Vol. 104; no. 12; pp. 968 - 970
Main Authors Erwin, John Preston, Iung, Bernard
Format Journal Article
LanguageEnglish
Published England 01.06.2018
Subjects
American Heart Association
Anticoagulants - adverse effects
Anticoagulants - therapeutic use
Atrial Fibrillation - diagnosis
Atrial Fibrillation - drug therapy
Atrial Fibrillation - epidemiology
Clinical Decision-Making
Consensus
Heart Valve Diseases - diagnosis
Heart Valve Diseases - drug therapy
Heart Valve Diseases - epidemiology
Humans
Practice Guidelines as Topic - standards
Risk Factors
Treatment Outcome
United States - epidemiology
United States
valvular heart disease
stroke
atrial fibrillation
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Commentary-2
content type line 23
ObjectType-Review-1
ObjectType-Editorial-3
ISSN:1355-6037
1468-201X
DOI:10.1136/heartjnl-2017-312758